CORT
Corcept Therapeutics Incorporated (CORT)
NASDAQ · Healthcare
Corcept Therapeutics Incorporated annual/quarterly shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Corcept Therapeutics Incorporated shareholder equity for the quarter ending December 31, 2025 were 647.8M, a 4.68% decrease year-over-year.
- Corcept Therapeutics Incorporated shareholder equity for 2025 were 647.8M, a 4.68% decrease from 2024.
- Corcept Therapeutics Incorporated shareholder equity for 2024 were 679.6M, a 34.12% increase from 2023.
- Corcept Therapeutics Incorporated shareholder equity for 2023 were 506.7M, a 0.97% increase from 2022.
- Corcept Therapeutics Incorporated shareholder equity for 2022 were 501.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Corcept Therapeutics Incorporated Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $648 |
| 2024 | $680 |
| 2023 | $507 |
| 2022 | $502 |
| 2021 | $376 |
| 2020 | $523 |
| 2019 | $371 |
| 2018 | $276 |
| 2017 | $191 |
| 2016 | $41 |
| Corcept Therapeutics Incorporated Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $648 |
| 2024-12-31 | $680 |
| 2023-12-31 | $507 |
| 2022-12-31 | $502 |
| 2021-12-31 | $376 |
| 2020-12-31 | $523 |
| 2019-12-31 | $371 |
| 2018-12-31 | $276 |
| 2017-12-31 | $191 |
| 2016-12-31 | $41 |
Corcept Therapeutics Incorporated Shareholder Equity — FAQ
Corcept Therapeutics Incorporated (CORT) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CORT's shareholder equity history?
The chart and table above show Corcept Therapeutics Incorporated's shareholder equity by year and by quarter, including the growth rate.